Advertisements promoting “100% safe,” “guaranteed treatments,” or “permanent cures” by Ayurvedic, homeopathic, or other traditional pharmaceutical companies are now under intense scrutiny. The Ayush Ministry has issued a warning to all manufacturers in these sectors, including Ayurveda, Siddha, Unani and Homeopathy, to strictly adhere to labeling and advertising regulations. Failure to comply may result in legal repercussions.
The move comes after the Supreme Court demanded a public apology from Patanjali following a controversy over its misleading advertisements. The Ayush Ministry, which News18 accessed, issued a clarification regarding products that display unsubstantiated claims and false information. For example, advertisements with a “green logo” that claim to be “100% vegetarian” or falsely state that the drug is “approved or certified by the Ministry” are also subject to this warning. included.
The Ayush Ministry has emphasized the importance of adhering to labeling regulations and advertising regulations for Ayurvedic, Unani, Siddha and homeopathic medicines. They provided details about the laws and regulations regulating misleading advertising in the country and urged manufacturers to strictly adhere to them. The advisory warns that misleading claims and advertisements, regardless of format or platform, are subject to legal action by competent authorities.
The Ministry of Ayush has directed state drug licensing authorities to scrutinize and ensure compliance of all medicines that claim to be “certified or approved by the Ministry of Ayush”, both on the label and in advertisements. The ministry has observed that some Ayush drug manufacturers have written “certified or approved by the Ministry of Ayush” on their drug labels and advertisements in print and electronic media.
The ministry clarified its role and said it would not grant manufacturing licenses or approvals to any Ayush medicines or products. However, it warned that the ministry could take legal action against the alleged manufacturer if it claims certification or approval from the Ayush Ministry for its labels or advertisements in the future.
This advisory excludes claims such as “100% safe,” “no side effects,” “guaranteed treatment,” or “permanent cure” associated with Ayush’s medicines and products, as well as claims of value for dietary supplements. He emphasized that it was accurate. It has been clarified that the approval granted by the State Drug Licensing Authority shall not be construed as approval by the Ministry of Ayush.
Additionally, the advisory states that licenses issued by state authorities only authorize the manufacture or sale of specific medicines or products, subject to compliance with the conditions outlined in the Drugs and Cosmetics Act, 1940. Masu. This recommendation was circulated to various authorities including: All state drug licensing authorities in Ayush have been requested to distribute it to all licensees within their jurisdictions. It was also sent to all Ayush pharmaceutical companies and their associations.
The recommendation was also forwarded to the National Pharmacovigilance and Coordination Center, which is responsible for monitoring and establishing the safety profile of medicines, including issuing alerts in case of newly reported side effects. The Center has been directed to ensure that claims of approval or certification from the Ministry of Ayush are reported to the relevant State Licensing Authority along with notification to the Ministry of Ayush.
The recommendation also refers to several existing laws governing the labeling of Ayurvedic, Siddha and Unani (ASU) medicines and the provisions for labeling of homeopathic medicines under Rule 106A of the Drugs and Cosmetics Rules, 1945. did. Additionally, it highlighted regulations related to: Ayush drug-containing advertisements are outlined in the Drugs and Magical Remedies (Offensive Advertisements) Act, 1954. These laws collectively provide guidelines and regulations to ensure proper labeling and advertising of Ayush drugs with the aim of protecting the interests and interests of consumers. Maintain standards within the industry.
In addition to the mentioned regulations, the advisory also highlighted other laws such as the Consumer Protection Act 2019. Cable Television Networks Act of 1995. The Emblems and Names (Prevention of Misuse) Act 1950 also contains provisions aimed at regulating misleading advertising.
Image source: Odisha Bytes
Disclaimer: The opinions expressed within this article are the personal opinions of the author. MyIndMakers is not responsible for the accuracy, completeness, suitability, or validity of the information in this article. All information is provided as is. The information, facts and opinions published in the article do not reflect the views of his MyindMakers and MyindMakers does not accept any responsibility for the same.
